Synapse - Hematology-Oncology Fellows

Results (1429)

Pan-cancer assessment of the impact of intronic variants on cancer development and progression

Meeting Abstract

Safonov, A.; Mehine, M.; Ceyhan-Birsoy, O.; Brown, D.; Bandlamudi, C.; Forbes, A.; Gazzo, A.; Selenica, P.; Shen, R.; Khurana, E.; more...
Annals of Oncology (2023)

Fulltext@MSK | Save

First-in-human study of ELU001, a targeted nanoparticle drug conjugate, in subjects with folate receptor α (FRα) overexpressing solid tumors

Meeting Abstract

Ma, W. W.; Orr, D.; Perez, C. A.; Murciano-Goroff, Y. R.; Hamilton, E. P.; Zhao, Y.; Anders, C.; Adams, G. P.; Reddick, C.; McClintock, H. W.; more...
Annals of Oncology (2023)

Fulltext@MSK | Save

Interim results from a phase I/II study of HPN328, a tri-specific, half-life (T1/2) extended DLL3-targeting T cell engager in patients (pts) with small cell lung cancer (SCLC) and other neuroendocrine neoplasms (NEN)

Meeting Abstract

Choudhury, N.; Jain, P.; Dowlati, A.; Thompson, J.; Johnson, M. L.; Mamdani, H.; Sanborn, R. E.; Schenk, E. L.; Aggarwal, R.; Sankar, K.; more...
Annals of Oncology (2023)

Fulltext@MSK | Save

Genomics of early progression on selpercatinib in patients with RET fusion-positive lung cancers

Meeting Abstract

Chen, M. F.; Rosen, E.; Falcon, C.; Repetto, M.; Yang, S. R.; Chang, J.; Kris, M. G.; Rekhtman, N.; Donoghue, M.; Drilon, A.
Annals of Oncology (2023)

Fulltext@MSK | Save

Nivolumab plus ipilimumab in advanced salivary gland cancer: A phase 2 trial

Journal Article

Vos, J. L.; Burman, B.; Jain, S.; Fitzgerald, C. W. R.; Sherman, E. J.; Dunn, L. A.; Fetten, J. V.; Michel, L. S.; Kriplani, A.; Ng, K. K.; more...
Nature Medicine (2023)

Fulltext@MSK | Save

Systematic evaluation of AML-associated antigens identifies anti-U5 SNRNP200 therapeutic antibodies for the treatment of acute myeloid leukemia

Journal Article

Knorr, K.; Rahman, J.; Erickson, C.; Wang, E.; Monetti, M.; Li, Z.; Ortiz-Pacheco, J.; Jones, A.; Lu, S. X.; Stanley, R. F.; more...
Nature Cancer (2023)

Fulltext@MSK | Save

Genomic and immune signatures predict clinical outcome in newly diagnosed multiple myeloma treated with immunotherapy regimens

Journal Article

Maura, F.; Boyle, E. M.; Coffey, D.; Maclachlan, K.; Gagler, D.; Diamond, B.; Ghamlouch, H.; Blaney, P.; Ziccheddu, B.; Cirrincione, A.; more...
Nature Cancer (2023)

Fulltext@MSK | Save

E7820, an anti-cancer sulfonamide, degrades RBM39 in patients with splicing factor mutant myeloid malignancies: A phase II clinical trial

Research Letter

Bewersdorf, J. P.; Stahl, M.; Taylor, J.; Mi, X.; Chandhok, N. S.; Watts, J.; Derkach, A.; Wysocki, M.; Lu, S. X.; Bourcier, J.; more...
Leukemia (2023)

Fulltext@MSK | Save

Challenges and solutions for therapeutic TCR-based agents

Review

Malviya, M.; Aretz, Z. E. H.; Molvi, Z.; Lee, J.; Pierre, S.; Wallisch, P.; Dao, T.; Scheinberg, D. A.
Immunological Reviews (2023)

Fulltext@MSK | Save

Creation of a quality improvement collaborative to address adolescent and young adult cancer clinical trial enrollment: ATAQI (AYA trial access quality initiative)

Journal Article

Hesko, C.; Mittal, N.; Avutu, V.; Thomas, S. M.; Heath, J. L.; Roth, M. E.
Current Problems in Cancer (2023)

Fulltext@MSK | Save